| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/10/2011 | CN101007074B Preparing method of Ginseng and Aconite preparation for injection |
| 08/09/2011 | WO2011097860A1 Pharmaceutical composition of levoamlodipine or pharmaceutically acceptable salts thereof and β blockers, and use thereof |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994317 sEH inhibitors and their use |
| 08/09/2011 | US7994282 Card proteins involved in cell death regulation |
| 08/09/2011 | US7994211 Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses |
| 08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 08/09/2011 | US7994196 Indazole compound and pharmaceutical use thereof |
| 08/09/2011 | US7994151 Compositions and methods for angiogenic therapy utilizing genes encoding ets-1 |
| 08/09/2011 | US7994134 Peptide-based compounds |
| 08/09/2011 | US7994131 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds |
| 08/09/2011 | US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters |
| 08/09/2011 | US7993849 Human TIMP-1 antibodies |
| 08/09/2011 | US7993829 HPRP4s modifiers of the p53 pathway and methods of use |
| 08/09/2011 | US7993643 Using low density lipoprotein receptor specific immunoglobulin for treatment and prevention of athersclerotic, kidney and inflammatory disorders |
| 08/09/2011 | CA2728997A1 Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and .beta. receptor blocking agent, and use thereof |
| 08/09/2011 | CA2567177C Genetically engineered cells for therapeutic applications |
| 08/09/2011 | CA2539707C Quinoline potassium channel inhibitors |
| 08/09/2011 | CA2512000C Selective estrogen receptor modulator |
| 08/09/2011 | CA2487297C The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 08/09/2011 | CA2441534C Benzoaxathiepin derivatives and their use as medicines |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2438595C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2428039C Serotonergic agents |
| 08/09/2011 | CA2422078C High efficiency cardiac gene transfer |
| 08/09/2011 | CA2370738C Uteroglobin in the treatment of iga mediated autoimmune disorders |
| 08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
| 08/09/2011 | CA2293415C Compositions for treating and preventing arterial thrombosis and use of a factor xa inhibitor on its own and/or combined with a platelet antiaggregating agent |
| 08/05/2011 | DE202006020979U1 Stabiles mikronisiertes Candesartan-Cilexetil Stable micronized candesartan cilexetil |
| 08/04/2011 | WO2011094579A2 Mushroom compositions and methods for making and using |
| 08/04/2011 | WO2011093851A1 Method for treatment of vascular hyperpermeability |
| 08/04/2011 | WO2011092690A1 Compositions and methods for prevention and treatment of pulmonary hypertension |
| 08/04/2011 | WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | WO2011091723A1 Neuregulin based compositions and uses thereof for preventing, treating or delaying the myocardial ischemia-reperfusion injury |
| 08/04/2011 | WO2011091461A1 Compounds for use in the treatment of diseases |
| 08/04/2011 | WO2011037913A3 Methods for preventing oxidative stress injury of a tissue by a folate-tempol conjugate |
| 08/04/2011 | WO2011019685A3 Second generation fatty acid compositions, formulations, and methods of use and synthesis thereof |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190876 Device for local and/or regional delivery employing liquid formulations of therapeutic agents |
| 08/04/2011 | US20110190730 Methods of inducing pluripotency involving oct4 protein |
| 08/04/2011 | US20110190729 Methods of inducing pluripotency involving sox2 protein |
| 08/04/2011 | US20110190515 Substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 08/04/2011 | US20110190395 Novel sulphur containing lipids for use as food supplement or as medicament |
| 08/04/2011 | US20110190394 Carnitine granulate and methods for its production |
| 08/04/2011 | US20110190387 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 08/04/2011 | US20110190383 Diagnostic, Prognostic and Therapeutic Uses of MIRs in Adaptive Pathways and/or Disease Pathways |
| 08/04/2011 | US20110190373 Methods and compositions for the treatment or prevention of pathological cardiac remodeling and heart failure |
| 08/04/2011 | US20110190366 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| 08/04/2011 | US20110190355 Heterocyclic indazole derivatives |
| 08/04/2011 | US20110190352 Use of dabigatranetexilate for treating patients with pulmonary hypertension |
| 08/04/2011 | US20110190346 Diphenyl Substituted Alkanes as Flap Inhibitors |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190341 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 08/04/2011 | US20110190340 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190329 Non-amidic linkers with branched termini as cgrp receptor antagonists |
| 08/04/2011 | US20110190324 Methods of treating atherosclerosis |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190317 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 08/04/2011 | US20110190314 Pharmaceutical compositions and their methods of use |
| 08/04/2011 | US20110190313 Treatment of Pulmonary Arterial Hypertension |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190302 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use |
| 08/04/2011 | US20110190300 Amide compounds and the use thereof |
| 08/04/2011 | US20110190298 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 08/04/2011 | US20110190296 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190292 Heterobicyclic compounds useful as kinase inhibitors |
| 08/04/2011 | US20110190287 Thrombocyte Inhibition Via Vivo-Morpholino Knockdown of Alpha IIB |
| 08/04/2011 | US20110190282 Novel vegf-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 08/04/2011 | US20110190278 Bicyclic heterocyclic derivative |
| 08/04/2011 | US20110190277 Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 08/04/2011 | US20110190266 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) |
| 08/04/2011 | US20110190263 Compounds and compositions as modulators of gpr119 activity |
| 08/04/2011 | US20110190258 Aryl benzylamine compounds |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190251 Method for inhibiting the build-up of arterial plaque by administering fullerenes |
| 08/04/2011 | US20110190249 Therapeutic methods and uses of sapogenins and their derivatives |
| 08/04/2011 | US20110190247 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 08/04/2011 | US20110190246 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 08/04/2011 | US20110190237 Macrocyclic Prodrug Compounds Useful as Therapeutics |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190210 Prominin-1 peptide fragments and uses thereof |
| 08/04/2011 | US20110190206 Reducing myocardial reperfusion injury by the combination therapy of protein kinase a activation and b1-adrenergic receptor blockade |
| 08/04/2011 | US20110190196 Improved peptide mediators of cholesterol efflux |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110190193 Treatment of endothelial dysfunction in diabetic patients |
| 08/04/2011 | US20110189318 Methods for enhancing the expression of intracellular redox-associated factors |
| 08/04/2011 | US20110189315 Plant extract and pufa combinations |
| 08/04/2011 | US20110189310 Small molecule modulators of prongf uptake |
| 08/04/2011 | US20110189300 siRNA SILENCING OF APOLIPOPROTEIN B |
| 08/04/2011 | US20110189286 Pulsatile Release of Valsartan |
| 08/04/2011 | US20110189285 Hydrogel capable of containing and conveying cells |
| 08/04/2011 | US20110189283 Appetising medicaments for oral administration in solid form for prevention and/or treatment of cardiac insufficiency in animals |
| 08/04/2011 | US20110189281 Telmisartan and hydrochlorothiazide combination therapy |
| 08/04/2011 | US20110189266 Corticosteroid microvesicles for treatment of cardiovascular diseases |
| 08/04/2011 | US20110189255 Drug-eluting stents for adenosine receptor modulation |
| 08/04/2011 | US20110189243 Pharmaceutical formulation for lowering pulmonary blood pressure |